The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.
about
Tamoxifen: catalyst for the change to targeted therapyTamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerThe gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis.Tamoxifen as the first targeted long-term adjuvant therapy for breast cancerEstrogen action: a historic perspective on the implications of considering alternative approaches.Tamoxifen: a most unlikely pioneering medicine.The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulatorsProven value of translational research with appropriate animal models to advance breast cancer treatment and save lives: the tamoxifen tale.Genotoxic mechanism of tamoxifen in developing endometrial cancer.Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis.The impact of molecular targets in cancer drug development: major hurdles and future strategies.Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case-Study in Pharmaceutical Innovation.Change in the gene expression of hepatic tamoxifen-metabolizing enzymes during the process of tamoxifen-induced hepatocarcinogenesis in female rats.Effects of cysteine on the pharmacokinetics of tamoxifen in rats with protein-calorie malnutrition.Arachidonic acid-containing phosphatidylcholine characterized by consolidated plasma and liver lipidomics as an early onset marker for tamoxifen-induced hepatic phospholipidosis.Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.New Hormonal Therapies for Breast Cancer.Tamoxifen Goes Forward Alone
P2860
Q24652988-05523DB3-DA12-4E4A-B508-00E5781AD0B1Q24670339-A9F6F098-06FF-460D-A6F3-AF25484D6D6FQ24685693-63E9DD7E-93E0-4C55-B1BD-EABD425D7CA4Q30957901-3B9A5E71-6DF8-4263-97DE-16255CFBB5E4Q33642104-3BCE2EBE-7724-47B4-ACEA-E06DBBC1CD61Q33709986-9C1F1830-B768-4710-9EE7-4CF1F05F640CQ34180688-BADC4B1B-7FEA-4DAE-B24A-63C046960746Q34315816-F6D6ED1A-AE54-4156-84A2-203DD6AEAD67Q35023715-F493C044-BC51-475B-9D12-36783A16EC64Q35828013-20C43C10-DB12-48D0-91B2-EC8440BFE9DBQ36364465-4711713B-4615-4E84-9896-9E390F01E175Q36684234-4EEB2EE4-8BBC-4AA9-BE3D-245023E1D7D3Q37376013-46C18D26-3ED1-49CD-BB82-A8CD8E52A259Q39494507-1DD0CA27-71DC-42F8-9559-3E6EA3219746Q41684474-EE5C09EB-5751-4981-82F4-109EDAAE1F73Q43918589-3F2B12E9-F68C-4EBC-AE90-FD3BABD6F3CEQ44693895-6BCEDA5D-8E9F-4C10-AB8D-3B4D4A41E6BEQ48295306-53CAAA0E-46FD-401A-8A80-5DFDF0114449Q50625597-9F3F1322-DDF0-46D4-A7FB-84F872E47AE6Q51802609-AED60C22-23F9-43DC-B080-34F1C5D1EE8FQ54056103-C5BBA20C-5B86-4165-8415-1F3AC53675C0Q54170777-5187EA4B-30DA-48E5-BE1E-093F2BCBB565
P2860
The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@en
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@nl
type
label
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@en
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@nl
prefLabel
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@en
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@nl
P2860
P356
P1476
The development of tamoxifen f ...... to the late Arthur L. Walpole.
@en
P2093
V C Jordan
P2860
P2888
P304
P356
10.1007/BF01807278
P407
P577
1988-07-01T00:00:00Z